Subclinical vascular disease in patients with diabetes is associated with insulin resistance

• Published in: Diabetes & metabolic syndrome clinical research & reviews 2019-05, Vol.13 (3), p.2198-2206
• Main Authors: Adeva-Andany, María M, Funcasta-Calderón, Raquel, Fernández-Fernández, Carlos, Ameneiros-Rodríguez, Eva, Domínguez-Montero, Alberto
• Format: Article
• Language: English
• Subjects: Diabetes Mellitus, Type 2 - complications; Humans; Insulin Resistance; Vascular Diseases - etiology; Vascular Diseases - pathology
• ISSN: 1871-4021; 1878-0334
• DOI: 10.1016/j.dsx.2019.05.025

Patients with diabetes experience increased cardiovascular risk that is not fully explained by deficient glycemic control or traditional cardiovascular risk factors such as smoking and hypercholesterolemia. Asymptomatic patients with diabetes show structural and functional vascular damage that includes impaired vasodilation, arterial stiffness, increased intima-media thickness and calcification of the arterial wall. Subclinical vascular injury associated with diabetes predicts subsequent manifestations of cardiovascular disease, such as ischemic heart disease, peripheral artery disease and stroke. Noninvasive detection of subclinical vascular disease is commonly used to estimate cardiovascular risk associated to diabetes. Longitudinal studies in normotensive subjects show that arterial stiffness at baseline is associated with a greater risk for future hypertension independently of established risk factors. In patients with type 2 diabetes, vascular disease begins to develop during the latent phase of insulin resistance, long before the clinical diagnosis of diabetes. In contrast, patients with type 1 diabetes do not manifest vascular injury when they are first diagnosed due to insulin deficiency, as they lack the preceding period of insulin resistance. These findings suggest that insulin resistance plays an important role in the development of early vascular disease associated with diabetes. Cross-sectional and prospective studies confirm that insulin resistance is associated with subclinical vascular injury in patients with diabetes, independently of standard cardiovascular risk factors. Asymptomatic vascular disease associated with diabetes begins to occur early in life having been documented in children and adolescents. Insulin resistance should be considered a therapeutic target in order to prevent the vascular complications associated with diabetes.